James H. Roth Sells 8,641 Shares of Huron Consulting Group Inc. (NASDAQ:HURN) Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth sold 8,641 shares of the stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $142.38, for a total transaction of $1,230,305.58. Following the completion of the transaction, the director now owns 47,638 shares of the company’s stock, valued at $6,782,698.44. This trade represents a 15.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Huron Consulting Group Stock Performance

Shares of NASDAQ HURN opened at $142.30 on Friday. The stock’s fifty day simple moving average is $136.15 and its 200 day simple moving average is $123.71. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of 30.93 and a beta of 0.53. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. Huron Consulting Group Inc. has a 52-week low of $84.26 and a 52-week high of $153.85.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.52 by $0.38. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The firm had revenue of $399.31 million for the quarter, compared to analysts’ expectations of $380.62 million. As a group, sell-side analysts forecast that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on HURN. Benchmark reaffirmed a “buy” rating and set a $165.00 price target on shares of Huron Consulting Group in a research note on Wednesday. Wedbush raised their target price on Huron Consulting Group from $150.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday. Truist Financial boosted their price target on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. William Blair restated an “outperform” rating on shares of Huron Consulting Group in a research report on Wednesday. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $167.00 price objective on shares of Huron Consulting Group in a research note on Thursday. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $169.25.

Institutional Investors Weigh In On Huron Consulting Group

Large investors have recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new position in Huron Consulting Group in the 4th quarter worth approximately $33,000. Tower Research Capital LLC TRC lifted its holdings in shares of Huron Consulting Group by 27.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider’s stock valued at $71,000 after purchasing an additional 122 shares in the last quarter. Cibc World Markets Corp purchased a new stake in shares of Huron Consulting Group in the fourth quarter valued at $204,000. Xponance Inc. acquired a new stake in shares of Huron Consulting Group in the fourth quarter worth $204,000. Finally, Two Sigma Securities LLC purchased a new position in shares of Huron Consulting Group during the fourth quarter valued at $209,000. Institutional investors and hedge funds own 93.90% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.